Miltaun en es it fr

Miltaun Brand names, Miltaun Analogs

Miltaun Brand Names Mixture

  • No information avaliable

Miltaun Chemical_Formula


Miltaun RX_link

No information avaliable

Miltaun fda sheet

Miltaun msds (material safety sheet)

Miltaun Synthesis Reference

No information avaliable

Miltaun Molecular Weight

309.469 g/mol

Miltaun Melting Point

< 25 oC

Miltaun H2O Solubility

Soluble as HCl salt

Miltaun State


Miltaun LogP


Miltaun Dosage Forms

Tablets (oral, 1 mg)

Miltaun Indication

Used for the symptomatic treatment of parkinsonism.

Miltaun Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltaun Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltaun side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltaun Patient Information

Miltaun Organisms Affected

Humans and other mammals